Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;16(3):400-5.
doi: 10.4103/2230-8210.95682.

Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders

Hemchand K Prasad  1 , Vaman V Khadilkar, Rahul Jahagirdar, Anuradha V Khadilkar, Sanjay K Lalwani
Affiliations

Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders

Hemchand K Prasad et al. Indian J Endocrinol Metab. 2012 May.

Abstract

Context: Gonadotrophin releasing hormone (GnRH) stimulation test is pivotal in the assessment of children with pubertal disorders. However, lack of availability and high cost often result in the test falling into disfavor. We routinely use the GnRH analogue stimulation test as an alternative at our center.

Aim: To present the data on children with endocrine disorders who underwent GnRH agonist stimulation test in pediatric endocrine clinic of a tertiary care referral hospital.

Setting and design: Pediatric endocrine clinic of a tertiary care referral hospital. Retrospective analysis of case records.

Materials and methods: The details pertaining to clinical and radiological parameters and hormonal tests were retrieved from case records of 15 children who underwent GnRH agonist stimulation test from May 2010 to April 2011.

Results: Indications for testing with GnRH analogue were evaluation of delayed puberty, diagnosis of precocious puberty, assessment of hormonal suppression in treatment of precocious puberty and micropenis in two, nine, three and one cases, respectively. The results of the test and clinical and radiological parameters were in concordance. The test was also crucial in diagnosing the onset of central precocious puberty in two children with congenital adrenal hyperplasia.

Conclusion: GnRH agonist test is a convenient, safe test that can be performed on an out-patient basis and can help the clinicians in the correct diagnosis and appropriate treatment of various puberty-related disorders.

Keywords: Analogue; gonadotrophin releasing hormone; puberty.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Job JC, Chaussain JL, Garnier PE. The use of luteinizing hormone-releasing hormone in pediatric patients. Horm Res. 1977;8:171–87. - PubMed
    1. Ahmed SF, Cheng A, Hughes IA. Assessment of the gonadotrophin–gonadal axis in androgen insensitivity syndrome. Arch Dis Child. 1999;80:324–9. - PMC - PubMed
    1. Kletter GB, Rolfes-Curl A, Goodpasture JC, Solish SB, Scott L, Henzl MR, et al. Gonadotropin-releasing hormone agonist analog (nafarelin): A useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab. 1996;9:9–19. - PubMed
    1. Garibaldi L. Disorders of pubertal development. In: Behrman RE, Kleigman RM, Jenson HB, editors. Nelson Text Book of Pediatrics. 18th ed. Philadelphia: WB Saunders; 2008. pp. 2309–11.
    1. Bajpai A. Precocious puberty. In: Desai MP, Bhatia V, Menon PS, editors. Pediatric Endocrine Disorders. 1st ed. Hyderabad: Orient Longman; 2001. pp. 217–41.